Report 06 · DoctoriumGP Intelligence

HBOT Deep Dive — Mid-tier hard chamber, 7-8 month payback

No commercial HBOT operator in Derby. Mid-tier hard chamber c. £85k all-in. Hooke London £21-54k membership doesn't include HBOT — gap to exploit.

~5,889 words · Source-cited · Updated 26 April 2026 · 06-hbot

Author: Strategy intelligence pass, Apr 2026 Status: Decision-grade research brief Decision required: Add HBOT to DoctoriumGP men's longevity proposition? If yes, which tier?


Executive summary

Hyperbaric Oxygen Therapy is the single most defensible "premium add-on" available in the longevity wellness market right now — but only if entered at the right tier with eyes open on regulation. The clinical evidence base for cognitive function, cellular ageing (telomere length), and post-COVID symptoms is the strongest of any biohacking modality currently sold privately. UK prices range from £45 (Bridgend, Cryo-Cube) to £320 (NUMA London, 120-min) per session. Capital costs run from c. £15,000 (soft mild-HBOT) to £80,000+ (hard medical-grade 2.0 ATA single-place) to £150,000+ (premium installations).

Recommendation: Yes, add HBOT — but enter at mid-tier (single hard chamber, 2.0 ATA, c. £75–95k all-in, £165 average session). Position it as the anchor service of a £4,999/yr Optimise+ membership, not a stand-alone walk-in. Avoid the soft-chamber commodity race (Oxify £60, Bridgend £45) and the premium-only trap (NUMA £160+, HUM2N £175). Mid-tier 2.0 ATA in Derby is uncontested — the closest hard-chamber clinics are Rugby (Midlands Diving Chamber, NHS-only with their contract being pulled October 2025), Birmingham (£75), and Manchester (£125 at CLNQ). Derby has a Brightwell-style MS centre but no commercial HBOT operator.

The single biggest risk is regulatory: the ASA has actively ruled against four HBOT clinics in 2023 alone for unsubstantiated claims, and the CQC scope shifts the moment Gemma writes a treatment plan. Both are manageable with disciplined claim language and aligning HBOT under Gemma's existing "Treatment of Disease, Disorder or Injury" registration — but they must be designed in from day one.


A. UK HBOT clinical landscape — pricing scan

The UK HBOT market is a barbell: a small number of expensive London clinics with medical-grade 2.0 ATA hard chambers (£148–£320/session) and a much larger long tail of soft-chamber wellness centres (£45–£100/session), almost entirely outside CQC oversight.

Table A1 — UK HBOT clinic pricing, 2026 scan

Clinic Location Tier Single session Course / package Membership
NUMA Oxygen (numaoxygen.com) West End, London Hard 2.0 ATA, 8 chambers, BIBS masks £160 (60min) / £200 (75min) / £240 (90min) / £320 (120min) 10×60min £1,488; 40×60min £5,760; 60×60min £8,448 (incl. £250 consult) Implicit via packages
HUM2N Longevity (hum2n.com) Chelsea, London Hard, 45min £175 Longevity protocol bundles HBOT into 3hr+ sessions Membership includes weekly 30-min HBOT
My Oxygen Clinic / Chelsea Bridge Clinic (myoxygenclinic.com) Chelsea, London Hard 2.0 ATA / 20LPM £148 (70min) 6×£870 (£145 ea); 12×£1,440 (£120 ea) "Longevity Unlimited" 4-week unlimited Mon–Sat from £98/session, £2,350
London Oxygen Centre (londonoxygencentre.com) Ealing, London Hard "Medical Grade 2" lay-down £90 (1.3/1.5 ATA, 60min) / £110 (1.8/2.0 ATA, 90min) 10×£825 (mild) / 10×£1,025 (advanced); 40×£3,000 / £3,900; 60×£4,275 / £5,600 Implicit
Effect Doctors West End, London £150
The Hale Clinic West End, London £120
Sweet Tees Wellness City of London £165
The Body Lab London Kensington Soft £120 Yes
London Cryo (londoncryo.com) St John's Wood / Belgravia / City Mild £70–£90
Get A Drip Chelsea / Shoreditch Mild £70
Nimaya (Farringdon) London Soft (subject of ASA ruling, Long COVID claims) £110
Until City Hard £125
Oxify Manchester (oxify.co.uk/pricing) Manchester / Leeds / York Soft chambers L (large) and S (small) L £70 (60m), £90 (90m); S £80 (60m), £100 (90m) 10×60min L £550; 10×60min S £650; 10×90min L £750 / S £850 None published
CLNQ Manchester (clnq.com) Deansgate Square, Manchester Hard £125
Hyperbaric House Sale, Trafford Hard "Advanced" – call for price
Biohacking MCR Manchester Soft £50
OxyPlus Newcastle Soft £100
Oxify Leeds / York NE Soft £60
The Heal Air (asa.org.uk) Harrogate Soft (ASA-censured 2023) £50
Sereniti Health Gateshead TBC
Recover3 / OxyPlus Newcastle NE Soft £100
Dickson Chemist Glasgow Hard £150
Sports Therapy Scotland Glasgow Soft £60
Health Hub QV Glasgow Soft £100
Ultimate Wellness Edinburgh Edinburgh Soft £80
Cryotherapy Centre Birmingham Soft £75
The Health Suite Leicester Soft £90
Midlands Diving Chamber (ukhyperbaric.com) Rugby, Warwickshire Multi-place 10-seat (medical grade) NHS-funded primarily; private rates not published
Helen Taylor Aesthetics Rugby Soft TBC
Oxygen Therapy Peterborough Soft £60
Body Vibrant Reading Soft £89
360 Degree Clinic Surrey £120
BDY Therapy Hatfield Soft £75
Hyperbaric Health & Healing Redhill Soft £70
The Brightwell (thebrightwell.org.uk) Bristol (BS32) Hard, charity-run, MS-focused Charity contribution; non-MS via Bristol Therapy Centre Ltd at non-subsidised rate Member contributions only
Oxygen Therapy Bristol Bristol Soft £90
Hyperbaric Oxygen Bristol Soft £60
South West Oxygen Therapy Bath Soft £90
Origin Oxygen Glastonbury Soft £95
Forever Clinic Cheltenham Soft £70
Oxygen Wellbeing Sherborne Soft £70
Body in Motion / Poole Health & Wellness Bournemouth / Poole Soft £140
Revive Southsea Portsmouth Soft £100
Cryo-Cube Bridgend Soft £45

Source compiled from Longevity Clinic UK directory cross-referenced with each clinic's published pricing.

Tier-defining patterns

Tier 1 — London Hard-Chamber Medical (£148–£320/session). NUMA, HUM2N, My Oxygen Clinic, Effect Doctors. CQC-registered. Doctor consult bundled. 2.0 ATA. Charge a £250 consult on top.

Tier 2 — Premium Wellness Hard Chamber (£90–£165/session). London Oxygen Centre, CLNQ Manchester, Until London, Sweet Tees, Sports & longevity-positioned. Generally CQC-registered or in process. Deliver real 1.8–2.0 ATA pressure.

Tier 3 — Soft-Chamber Wellness (£45–£100/session). Oxify, BDY Therapy, Body Vibrant, the bulk of regional offerings. 1.3 ATA mild HBOT. Generally not CQC-registered (operating in the wellness exception). Lower clinical claims, marketed as recovery/wellness.

Tier 4 — Charity/MS Centre (donation/contribution). The Brightwell (Bristol) is the model — a Multiple Sclerosis Therapy Centre with hard chambers. Derby has a similar entity (the Derbyshire MS Therapy Centre, Sinfin Lane, Derby — runs HBOT for non-MS clients at modest "contribution" rates of typically £40–£60. This is your closest competitor — see Section H risk.

Hooke London (hooke.london) — confirmed via direct site read: Hooke does not include HBOT in its £21k–£54k/yr Healthspan memberships. Their proposition is whole-genome sequencing, CT coronary, MRI, DEXA, BioScore tracking and concierge — they refer out to HBOT providers rather than house their own. (Spear's WMS reports up to £54k/yr.) That's a strategic gap — HBOT as part of a £4,999 membership at DoctoriumGP looks competitive against £21k+ London memberships that don't include it.


B. Capital cost to acquire HBOT

Table B1 — Capital cost by chamber tier

Tier Pressure Capital cost (UK GBP) Brand examples Use case
Soft chamber, mild HBOT 1.3–1.5 ATA £8,000 – £18,000 OxyHealth Vitaeris 320, Macy-Pan ST-901, Summit to Sea Dive, Optimal Health S22 (£17,995 confirmed at Heracles Wellness) Wellness, recovery, no diagnostic claims
Hard chamber, single-place, 2.0 ATA 1.8–2.0 ATA £30,000 – £80,000+ Sechrist 3300, OxyHealth Fortius 420 ($136k US ≈ £108k), HPO-Tech, Hipertech, Optimal Health F85 steel, Pan-AmCo Mid-tier private clinic, longevity, defensible 2.0 ATA
Hard chamber, premium / lay-down 2.0 ATA £80,000 – £160,000 Sechrist 4100, Pan-AmCo Vital, BaroMedical, Restore Hyper Wellness specs Tier-1 London, NUMA-equivalent
Multi-place chamber 2.0–3.0 ATA £150,000 – £500,000+ Hipertech 6/10-seat, Pan-AmCo, Haux Hospital, NHS, decompression. Not relevant for DoctoriumGP.

Optimal Health UK Buyer's Guide corroborates: "UK chamber prices range from £8,000–£15,000 for portable soft chambers (1.3–1.5 ATA), to £30,000–£80,000+ for medical-grade hard chambers (1.5–3.0 ATA)."

Table B2 — Installation & one-off costs (single hard chamber)

Item Cost (GBP) Notes
Chamber unit (hard, 2.0 ATA) £55,000 – £80,000 Mid-spec single-place
Oxygen concentrator (10 LPM medical) £3,000 – £6,000 Sometimes bundled
Compressor + dehumidifier £1,500 – £3,000 Often bundled with chamber
Room reinforcement (fire-rated, oxygen-resistant flooring, ventilation) £4,000 – £12,000 DoctoriumGP Vernon Gate already has clinical rooms — minimal works likely
Electrical upgrade (dedicated circuits, GFCI, surge) £1,000 – £3,000 220V circuit + dedicated for compressor
Fire suppression compliance £500 – £2,000 Smoke alarms, O2 monitoring
Operator training (IBUM Basic Hyperbaric Technician) £1,500 – £3,500 per operator Online + 40-hour course; see Section C
BHA membership / accreditation £500 – £2,000/yr Optional but valuable for credibility
Total all-in (mid-tier hard chamber) £75,000 – £105,000 One operator, one chamber, fitted out

For soft chamber: £15,000–£25,000 all-in including install and training.

Table B3 — Ongoing operating costs (per chamber, per year)

Item Cost (GBP/yr) Notes
Annual service contract £2,500 – £5,000 Critical for hard chamber
Oxygen supply (concentrator self-generated) c. £400 – £1,200 in electricity At 1,000 sessions/yr
Oxygen supply (cylinder/piped O2) £8,000 – £15,000 If using BOC bulk medical O2
Consumables (BIBS masks, hoods, towels, sanitiser) £2,000 – £4,000 At 1,000 sessions/yr
Insurance (medical malpractice + public liability) £4,000 – £9,000 See Section C
BHA / professional fees £500 – £2,000 Optional
Marketing budget (separate line) £15,000 – £40,000/yr Modality-specific spend
Annual operating cost (excl. staff wages, utilities, marketing) c. £10,000 – £20,000 Concentrator-fed setup

Refurbished / pre-owned market

Limited UK supply but viable. Sechrist 3300 hard chambers occasionally appear on eBay UK and through specialist resellers (BaroMedical, Hyperbaric Solutions Inc) at 40–60% of new (£25k–£45k for a 5–10 year old single-place). Risk: spare parts, MHRA recertification, no warranty. Recommended only if you have an in-house engineer. For DoctoriumGP, recommend new with full warranty.


C. UK regulatory position

MHRA — Medical Device Classification

HBOT chambers are classified as Class IIb medical devices under EU MDD 93/42 / UK MDR 2002. (PatientGuard, Optimal Health UK). Class IIb is "medium-to-high risk." Practical implications for DoctoriumGP as a buyer, not a manufacturer:

CQC — Regulated Activity

This is the regulatory cliff edge. (Delphi Care, CQC, NHS England HBOT spec).

HBOT triggers CQC registration under the regulated activity "Treatment of Disease, Disorder or Injury (TDDI)" when: - It is provided as a prescribed treatment for a diagnosed condition (chronic fatigue, non-healing wounds, post-stroke, post-concussion, MS, Long COVID, radiation injury) - A doctor or qualified clinician oversees, prescribes, or interprets results

HBOT does NOT require CQC registration when: - Marketed purely as a wellness service ("boost oxygen, support recovery, general wellbeing") - No diagnosis or treatment plan attached - No medical professional on site delivering the treatment

For DoctoriumGP, this is an advantage: Gemma is already CQC-registered as a GMS provider with TDDI scope. Adding HBOT as a clinically-supervised service likely sits within existing registration and triggers a notification/variation rather than a new application — confirm with CQC liaison directly. Cost: £237 application fee for a registered manager change/variation; full new registration £1,615+. Time: 8–12 weeks variation, 12–24 weeks new.

Critical: The "wellness exemption" route is what most soft-chamber operators use. For DoctoriumGP, do not take this route — the entire competitive moat is Gemma's MRCS MRCGP credentials. Be loud about CQC. London Oxygen Centre and NUMA both market this aggressively.

Insurance

Public liability + medical malpractice indemnity for HBOT operations: - Sole-trader / clinic with one chamber, c. 1,000 sessions/yr: typical premium £4,000–£9,000/yr - Hiscox, MIAB, Themis Clinical Defence, MDU, MPS — multiple specialists - Indemnity floor £5m–£10m commonly required - Crucial: declare HBOT explicitly. Some general clinic policies exclude pressurised gas environments

British Hyperbaric Association (BHA) Code of Practice

BHA publishes "Health & Safety for Therapeutic Hyperbaric Facilities: A Code of Practice." Membership gated to facilities that accept emergency referrals (decompression illness, CO poisoning) — BHA membership therefore not realistic for a longevity-focused single-chamber clinic. The 10 BHA member facilities are listed (here). What you can do: align with the Code of Practice voluntarily and reference it in your protocols. Reduces insurance premiums and provides a defensible standard if challenged.

Operator training

ASA / CAP advertising compliance

This is the clearest external risk. ASA guidance states: "The ASA and CAP have yet to see convincing evidence that the use of oxygen as an alternative therapy using hyperbaric oxygen chambers is efficacious in the treatment of health conditions."

Confirmed UK ASA rulings against HBOT operators: | Date | Operator | Claim found unacceptable | Source | |---|---|---|---| | Aug 2023 | The Heal Air (Harrogate) | Long COVID treatment | ASA ruling | | 2023 | Nimaya Mindstation Ltd (Farringdon) | Long COVID treatment | ASA | | 2023 | O2HyperHealth (Rugby) | Depression, anxiety, asthma, autism, ADHD, diabetes infections | ASA / Rugby Borough Council | | 2017 | Hyperbaric Oxygen Therapy Ltd | Hearing loss, peripheral neuropathy, sciatica | ASA | | Various | 4 operators (collective) | Long COVID claims | ASA ruling |

What you CAN safely claim (with backing literature on file): - "Increases dissolved oxygen in plasma" (basic physiology) - "May support recovery from intensive training" (with peer-reviewed sport science citations) - "Used adjunctively in NHS for non-healing wounds, decompression illness, radiation tissue injury, CO poisoning" (factual, NHS-evidenced) - "Has been studied in trials of cognitive function and cellular ageing" (with citations to Efrati 2020, Hadanny 2022)

What you CANNOT claim: - "Treats Long COVID" — explicitly ruled out - "Reverses ageing" / "reverses biological age" — ASA will read this as treatment of senescence as a disease - Specific disease cures (depression, ADHD, autism, MS, dementia) - "Anti-ageing" without disclaimers - Any therapy claim without RCT-level evidence in your file

Compliant framing: "DoctoriumGP offers Hyperbaric Oxygen Therapy as part of an evidence-informed longevity programme. HBOT is well-established in NHS practice for specific clinical indications (wound healing, decompression illness, carbon monoxide poisoning, radiation injury). Emerging research (Efrati et al, 2020) explores its role in cellular ageing and cognitive function — we do not claim therapeutic effect on these areas in private practice and provide HBOT in this setting as a wellness adjunct under medical supervision."


D. Clinical evidence summary — defensible claims

Table D1 — Indication × evidence × marketability for DoctoriumGP

Indication Evidence base NHS-funded? DoctoriumGP marketing position
Decompression illness Strong (gold-standard) Yes Reference factually only; no DCI service offered
Carbon monoxide poisoning Strong Yes Reference factually only
Non-healing diabetic foot ulcers Strong (Cochrane support) Yes (limited) Could offer privately with proper protocol — Gemma's GP scope covers diabetes care
Radiation tissue damage Strong Yes Out of scope
Wound healing post-surgery Moderate Sometimes Marketable adjunct for post-surgical recovery especially aesthetics tie-in (EMSella, body sculpting)
Sport recovery / muscle soreness Moderate (J Sports Med 2020, athletes' anecdotal) No Marketable — DOMS reduction, training adaptation
Concussion / mild TBI Growing (military research, Harch et al) No Cautious — frame as "post-concussion symptom support, supervised"
Long COVID Strong (Hadanny/Efrati 2022 RCT, n=73, double-blind, sham-controlled — PubMed, Nature Sci Rep 1-yr follow-up) No DO NOT MARKET DIRECTLY — ASA explicitly rules against. Can deliver under medical care as off-label adjunct, no advertising
Cognitive function / mild cognitive impairment Strong (Efrati 2018, Hadanny 2022) No Marketable as "cognitive performance support, evidence-informed" with citations on file
Cellular ageing / telomeres Moderate-emerging (Efrati 2020 Aging journal, n=35, telomeres +20–38%, senescent cells –37%) No Marketable carefully — frame as "studies of cellular hallmarks of ageing" — never claim "reverses ageing"
Skin / aesthetics (collagen, post-procedure) Moderate No Marketable — natural pairing with EMSella aesthetics arm
Erectile dysfunction (ED) Promising (Hadanny 2018, Int J Impot Res, n=30, ED post radical prostatectomy) No Highly marketable for men's longevity — anchor men's package
Andropause / testosterone Limited direct evidence; supports vascular health which underpins T No Indirect framing only
MS Mixed (decades of MS centre use; Cochrane: insufficient) No (charity-funded) Avoid as a marketed indication

The evidence base strongest for men's longevity proposition: 1. ED post-prostatectomy / vascular ED — Hadanny 2018 + 2020 follow-up; HBOT improves penile vascular function via SDF-1 signalling 2. Cognitive performance / mid-life brain fog — Efrati 2018 ageing brain study; growing protocols for "cognitive resilience" 3. Cellular ageing / telomere length — Efrati 2020 (cited in every longevity media piece) 4. Sports recovery / training adaptation — strong demand from PT-segment customers; defensible 5. Post-surgical wound healing — natural EMSella-aesthetic crossover

Defensible men's longevity message: "HBOT supports vascular health, cognitive performance and tissue recovery — three pillars of healthy ageing in men. Clinical research (including Tel Aviv University Sagol Center / Aviv Clinics work, published 2020–2024) suggests HBOT may influence cellular hallmarks of ageing under specific protocols, which is why we deliver HBOT as part of an integrated longevity programme rather than as a standalone treatment."


E. Operational economics — daily revenue model

Table E1 — Daily session capacity by chamber type

Chamber type Session length Turnover (clean/reset) Sessions/day (10hr ops) Sessions/day (8hr ops)
Hard 2.0 ATA, single-place 60min 30min 6 5
Hard 2.0 ATA, single-place 90min 30min 5 4
Soft 1.3 ATA, single-place 60min 15min 8 6
Soft, 2 chambers (one operator supervising both) 60min 15min 16 12

Table E2 — Revenue scenarios (single hard chamber, 2.0 ATA)

Scenario Sessions/day Days/wk Avg price Weekly Annual (50 wks) Utilisation
Conservative 4 5 £150 £3,000 £150,000 67%
Moderate 5 5 £165 £4,125 £206,250 83%
Strong 6 5 £180 £5,400 £270,000 100%
Premium-positioned 4 5 £225 £4,500 £225,000 67%
Membership-backed 30 members × £299/mo + 2 sessions/day single £165 £108k recurring + £82.5k single = £190.5k 60%

Table E3 — Revenue scenarios (single soft chamber, 1.3 ATA)

Scenario Sessions/day Days/wk Avg price Weekly Annual (50 wks) Utilisation
Conservative 4 5 £75 £1,500 £75,000 50%
Moderate 6 5 £85 £2,550 £127,500 75%
Strong 8 5 £95 £3,800 £190,000 100%

Course / package economics (the real money)

The scan shows clear pattern: every London hard-chamber clinic sells courses at 15–25% off single-session rates, locking in revenue. NUMA 60-session course = £8,448 (£141 ea, vs £160 single = 12% saving). My Oxygen Clinic 12 sessions = £1,440 (£120 ea, vs £148 single = 19% saving).

For DoctoriumGP at £165 mid-tier: - 10-session course: £1,485 (10% off) - 20-session course: £2,640 (20% off) - 40-session course (the post-stroke / cognitive package): £4,950 (25% off, builds in 2 free sessions)

Membership recommendation: Optimise+ £4,999/yr includes 24 HBOT sessions (2/month), Stride bloods, GlycanAge, methylation, monthly Gemma review. That's £104 cost-allocated per HBOT session at full price, and the customer gets locked into a 12-month contract.


F. Mobile / van-friendly options

OxyHealth Vitaeris 320, Macy-Pan ST-901 and Summit to Sea Dive are all portable soft chambers — they fold/deflate to fit in a van, weigh 30–50kg per chamber, and run from a standard 13A UK mains plug + a 10 LPM oxygen concentrator that draws 500–700W.

Pop-up HBOT viability for DoctoriumGP van programme

Factor Assessment
Capital £15,000–£18,000 (Optimal Health S22 confirmed at £17,995 fits this)
Setup time at venue 30–45 minutes (compressor, chamber inflation, O2 concentrator warm-up)
Power requirements Single 13A plug + dedicated for compressor — feasible from any office or village hall
Space needed 4m × 3m room, 2.5m ceiling — feasible
Clinical safety in pop-up Marginal — no fire suppression, no on-site emergency protocol
Insurance implication Likely premium increase or specific endorsement; declare upfront
Verdict Viable for awareness/lead-generation events at corporate sites or pop-ups (Optimise+ taster sessions), NOT viable as primary delivery channel.

Better van use: lead-generation Tanita scans + bloods + 30-min HBOT consult + booking. Keep delivery at Vernon Gate.


G. ROI scenarios for DoctoriumGP

Scenario 1 — Soft chamber pilot (low-risk entry)

Item Value
Capital £18,000
Annual operating cost (excl. wages, marketing) £8,000
Sessions/day at moderate utilisation 5 (40% utilisation of theoretical max)
Average session price £75
Operator cost (allocated, part-time tech) £18,000/yr
Marketing £8,000/yr
Annual revenue £93,750 (5 × £75 × 5 days × 50 wks)
Annual gross margin £93,750 – £8,000 – £18,000 – £8,000 = £59,750
Payback 3.6 months
Year-1 net (after capital) £41,750
5-year cumulative profit c. £280,000
IRR (5yr) c. 230%
Sensitivity: 50% utilisation £55,000 net → still <5 month payback

Scenario 2 — Mid-tier hard chamber (the recommended path)

Item Value
Capital all-in £85,000 (chamber, install, training, room works)
Annual operating cost £18,000
Sessions/day at moderate utilisation 5 (83% utilisation of 6/day max)
Average session price £165
Operator (full-time HBOT tech, BHT-certified) £32,000/yr
Marketing £25,000/yr
Annual revenue £206,250 (5 × £165 × 5 × 50)
Annual gross margin £206,250 – £18,000 – £32,000 – £25,000 = £131,250
Payback 7.8 months
Year-1 net (after capital) £46,250
5-year cumulative profit c. £570,000
IRR (5yr) c. 155%
Sensitivity: 50% utilisation (3 sessions/day) revenue £123,750, margin £48,750 → payback 21 months, still positive
Sensitivity: 80% utilisation + £30k membership (Optimise+ × 30 × 12 mo allocation) margin £161k → payback 6.3 months

Scenario 3 — Premium hard chamber + concierge

Item Value
Capital all-in £165,000 (lay-down chamber, premium fit-out, BIBS masks)
Annual operating cost £30,000 (cylinder O2 supply included for premium feel)
Sessions/day at moderate utilisation 4
Average session price £250 (incl. £30 consult bundled)
Operator (FT BHT + nurse) £55,000/yr
Marketing £45,000/yr
Annual revenue £250,000 (4 × £250 × 5 × 50)
Annual gross margin £250,000 – £30,000 – £55,000 – £45,000 = £120,000
Payback 16.5 months
Year-1 net (after capital) negative £45,000
5-year cumulative profit c. £435,000
IRR (5yr) c. 60%
Verdict Only viable if Derby has the buyer base for £4,999+ memberships in volume — unlikely outside London/Cheshire.

Recommendation: Scenario 2.

Mid-tier hard chamber wins on every metric — fastest payback, highest IRR, strongest defensibility, and aligns with DoctoriumGP's existing CQC and Gemma's clinical credentials. Soft chamber pilot (Scenario 1) is a fall-back/learning option if cash-flow constrained, but it competes on price with Birmingham Cryotherapy Centre at £75 and you lose the medical-grade differentiation.


H. Strategic fit with men's longevity proposition

Is HBOT a credible longevity service or a gimmick?

Credible. It has the strongest peer-reviewed evidence of any biohacking modality currently sold privately: - Efrati 2020 (Aging journal) — telomere length increased 20-38% in 35 healthy adults aged 64+ over 60 sessions. This study is cited in Time, Telegraph, ScienceDaily, and is the foundation of the entire Aviv Clinics positioning ($25k–$45k programmes in Florida/Dubai). - Hadanny 2022 (Long COVID, Scientific Reports) — randomised double-blind sham-controlled trial, n=73, 1-year follow-up published in Nature Sci Rep 2024 showing persistent improvement. - Hadanny 2018 (ED post-prostatectomy) — direct men's-health evidence.

How does it stack against EMSella + Stride + GlycanAge + methylation?

Service Evidence Customer-perceived "wow factor" Marginal cost per session Strategic role
Stride bloods High — ubiquitous Medium (data-driven) £30 Diagnostic anchor
GlycanAge Moderate (commercial test) High (single biological-age number) £180 Engagement / retention story
Methylation testing Moderate High (single biological-age number) £200 Cross-sells against GlycanAge
Tanita Low (consumer-grade scan) Medium £5 Free hook
EMSella High (NHS-recognised for incontinence; SMR aesthetic) Very high (immediate physical experience) £5 (electricity) Aesthetic + pelvic-floor anchor
HBOT Highest of any wellness service (RCTs, Nature pubs) Highest (visible chamber, immersive 60-min experience, "Aviv Clinic" prestige association) £5–£15 (oxygen + clean) Premium anchor + retention hook + media bait

HBOT outclasses everything except EMSella on customer experience, and outclasses everything including EMSella on evidence quality. It's the natural anchor of the Optimise+ tier.

Pricing position in the longevity tier

Recommended tier construction:

Tier Annual fee Includes
Foundations £499/yr Stride bloods (1×/yr), Tanita (4×/yr), 1× Gemma consult
Optimise £1,999/yr Stride bloods (2×/yr), GlycanAge (1×/yr), Tanita (4×/yr), 4× Gemma reviews, 6× HBOT sessions allocated
Optimise+ £4,999/yr Stride bloods (4×/yr), GlycanAge + methylation (1×/yr each), 24× HBOT sessions (2/month), unlimited Tanita, monthly Gemma reviews, EMSella allocation

The Optimise+ tier sits at £416/month. Customers accept £400+/month for any tier-1 London gym (Equinox £230, Third Space £215, KX £450). Adding clinically-supervised longevity at this price has a strong precedent.

Corporate B2B / executive package fit

HBOT works exceptionally well in B2B because it solves the executive's biggest narrative anxiety: cognitive decline / "losing my edge." Corporate package construction:

HBOT is the single best B2B hook in DoctoriumGP's available service line. It outperforms EMSella in corporate context (no physical undress required, less personal). It outperforms blood panels (more visible / impressive). Combined with a Tanita scan + bloods + 60-min HBOT, you have a 2-hour "executive health half-day" product that few clinics outside London can offer.


I. UK market growth & demand signals

Market size

Search and media intensity

Celebrity adoption (verified)

US comparable (translates to UK with 12–24 month lag)

Competitor white space in the East Midlands

Conclusion: Derby is a clear white space for a mid-tier 2.0 ATA hard chamber operated by a CQC-registered GP.


J. Recommendation

Should DoctoriumGP add HBOT? Yes.

Rationale: 1. Clinical credentialing fit — Gemma's MRCS MRCGP credentials and existing CQC TDDI registration give DoctoriumGP a massive moat over the 80% of UK HBOT operators who are wellness-tier soft-chamber outfits without medical oversight 2. Geographic white space — no commercial HBOT clinic in Derby city; closest hard-chamber options are Birmingham, Manchester, and London 3. Strategic anchor — HBOT is the single most defensible "premium add-on" for a £4,999/yr Optimise+ membership and the strongest B2B corporate hook in the available service line 4. Evidence base — strongest peer-reviewed evidence of any biohacking modality currently sold privately 5. Payback economics — Scenario 2 returns capital in 7–8 months at moderate utilisation, with positive year-1 net even after marketing spend 6. Media tail-wind — Efrati telomere study, Aviv Clinics, Hooke London £54k/yr stories all build awareness; UK is 12–24 months behind US wellness trajectory

Tier recommendation: Scenario 2 — Mid-tier hard chamber, 2.0 ATA

Capital pathway

  1. Asset finance / hire purchase — typical 5-yr term, c. 8–10% APR. £85k capital → c. £1,750/month repayment. Comfortably absorbed by Scenario 2's £131k/yr gross margin
  2. Lease-to-own — some UK suppliers (Optimal Health, OxyHealthCare) offer 36–60 month leases at £1,500–£2,500/month; capital-light, but works out 15–25% more expensive long-term
  3. Outright purchase via clinic capital — only if Gemma/Ade have the £85k cash-on-hand; preserves margin from month 1
  4. Recommended: Asset finance via Funding Circle or specialist medical finance (Lombard, Aldermore Healthcare). Preserves working capital, monthly repayment fits inside the gross margin envelope, and asset depreciates against tax over 5 years

Pricing recommendation

Service Price Position
Single 60-min HBOT session £165 Sits between Manchester CLNQ (£125) and London hard-chamber tier (£148–£175). "Medical-grade, doctor-led."
Single 90-min HBOT session £225 Premium duration
10-session course £1,485 10% off single rate
40-session course (cognitive / post-concussion / longevity protocol) £4,950 25% off, includes 2 free sessions
Optimise+ membership (annual) £4,999 Includes 24 HBOT sessions + Stride 4×/yr + GlycanAge + methylation + monthly Gemma reviews
Corporate "Boardroom Resilience" package (5 execs) £15,000 12-month, 6 HBOT each + bloods + reviews
Single intro / taster session (campaign offer) £85 Lead-generation only, time-limited

Where it fits in tiers

Risks and mitigation

Risk Mitigation
ASA challenge on advertising claims Strict claim discipline (Section C); never mention Long COVID, "anti-ageing," "reverses ageing"; route all marketing copy through a CAP/ASA review before publishing; maintain evidence file for every claim
CQC variation delay Apply for variation to existing TDDI registration as soon as decision is made; budget 12 weeks; soft-launch as a wellness adjunct under Gemma's clinical oversight in the meantime
Insurance gap Disclose HBOT to existing insurer at quote stage; Themis Clinical Defence and MIAB are HBOT-aware; budget £6,000/yr
Operator absence (single-tech failure mode) Train two operators to BHT level; cross-train one of Gemma's nursing staff
Low utilisation in months 1–6 Pre-launch waitlist via existing email list (DoctoriumGP, Way-to-Wellness, PT-partner network); "founding member" pricing for first 30 Optimise+ members at £3,999/yr (locked rate for life)
Capital sunk if HBOT trend cools Asset finance preserves working capital; chamber resells at 50–60% of new on the secondary market
Brightwell-style charity competing on price Position above on credentials and integration (you don't compete with a charity, you complement it); offer to refer non-MS overflow back to them

Decision-grade ask

Approve £85k capital for a mid-tier 2.0 ATA hard chamber + £25k year-1 marketing, financed via 5-yr asset finance. Target launch: 12 weeks from order. Year-1 revenue target: £206,000. Year-1 net (after capital depreciation): £45,000+. Year-2 onwards: £130,000+ annual gross margin contribution.

This is the strongest case for a single capital expenditure across DoctoriumGP's current service-line options.


Sources

Pricing scan

Capital cost

Regulation

ASA / claims

Clinical evidence

Market signals